ArticleProceedings of the National Academy of Sciences of the United States of America2022

Development of DG9 peptide-conjugated single- and multi-exon skipping therapies for the treatment of Duchenne muscular dystrophy.

Kenji Rowel Q Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.